A Debate on Vitamin C: Supplementation on the Hotline for Critically Ill Patients with COVID-19

Código QR

A Debate on Vitamin C: Supplementation on the Hotline for Critically Ill Patients with COVID-19

Guardado en:

Detalles Bibliográficos
Autores principales:	Ata Mahmoodpoor, Ali Shamekh, Sarvin Sanaie
Formato:	article
Lenguaje:	EN
Publicado:	Tabriz University of Medical Sciences 2020
Materias:	Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/4797c817e10e44fb9d08852c3168076b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Potential benefit of vitamin D supplementation in people with respiratory illnesses, during the COVID‐19 pandemic
por: Vasudevan V. Chetty, et al.
Publicado: (2021)

The Parkinson's disease death rate: carbidopa and vitamin B6
por: Hinz M, et al.
Publicado: (2014)

Administration of supplemental L-tyrosine with phenelzine: a clinical literature review
por: Hinz M, et al.
Publicado: (2014)

A clinical evaluation to determine the safety, pharmacokinetics, and pharmacodynamics of an inositol-stabilized arginine silicate dietary supplement in healthy adult males
por: Kalman DS, et al.
Publicado: (2015)

Reducing medication errors in critical care: a multimodal approach
por: Kruer RM, et al.
Publicado: (2014)

Efficacy and safety of antithrombotic therapy with non-vitamin K antagonist oral anticoagulants after transcatheter aortic valve replacement: a systematic review and meta-analysis
por: Qing An, et al.
Publicado: (2021)

Ad Hominem Criticisms: An Old Trick to Discredit Inconvenient Research. A Response to Oakley et al. And the International Chiropractors Association Rapid Response Research Review Subcommittee
por: Pierre Côté, et al.
Publicado: (2021)

Carbon monoxide: a critical quantitative analysis and review of the extent and limitations of its second messenger function
por: Levitt DG, et al.
Publicado: (2015)

Chronic hepatitis C: future treatment
por: Wendt A, et al.
Publicado: (2014)

Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS‐CoV‐2
por: Russell M. Petrak, et al.
Publicado: (2021)

Smoke Screen to Distract From Flawed Science: A Response to Côté et al. Over Criticisms to Their Deficient ‘Rapid Review’ on Chiropractic X-Ray Utility
por: Paul A. Oakley, et al.
Publicado: (2021)

Vitamin D and inflammatory diseases
por: Yin K, et al.
Publicado: (2014)

Multiscale model of hepatitis C virus dynamics in plasma and liver following combination therapy
por: Xavier Woot de Trixhe, et al.
Publicado: (2021)

A prospective, observational study comparing the PK/PD relationships of generic Meropenem (Mercide®) to the innovator brand in critically ill patients
por: Mer M, et al.
Publicado: (2016)

Dose Optimization of Vancomycin for Critically Ill Patients Undergoing CVVH: A Prospective Population PK/PD Analysis
por: Chuhui Wang, et al.
Publicado: (2021)

Management of chronic hepatitis C virus infection in patients with end-stage renal disease: a review
por: Aguirre Valadez J, et al.
Publicado: (2015)

Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response
por: Li L, et al.
Publicado: (2012)

Virtual clinical trial simulations for a novel KRASG12C inhibitor (ASP2453) in non‐small cell lung cancer
por: Hiroyuki Sayama, et al.
Publicado: (2021)

Commentary of the mRNA vaccines COVID-19
por: Antonio Vitiello, et al.
Publicado: (2021)

Association of Diabetes and Admission Blood Glucose Levels with Short-Term Outcomes in Patients with Critical Illnesses
por: Lin S, et al.
Publicado: (2020)

Sodium Bicarbonate Nebulized Therapy in Patients with Confirmed COVID-19
por: Jalil Rashedi, et al.
Publicado: (2020)

ACE2 : S1 RBD Interaction-Targeted Peptides and Small Molecules as Potential COVID-19 Therapeutics
por: Lennox Chitsike, et al.
Publicado: (2021)

Bacteriocin-mediated inhibition of some common pathogens by wild and mutant Lactobacillus species and in vitro amplification of bacteriocin encoding genes
por: Arooj Ahsan, et al.
Publicado: (2021)

RETRACTION NOTICE: A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients
Publicado: (2021)

Author response to: correspondence to: ‘A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients’
por: Jin-Tao Guan, et al.
Publicado: (2021)

Administration of Supplemental L-Tyrosine with Phenelzine: a Clinical Literature Review [Retraction]
por: Hinz M, et al.
Publicado: (2021)

<i>Commiphora myrrh</i> Supplementation Protects and Cures Ethanol-Induced Oxidative Alterations of Gastric Ulceration in Rats
por: Mohamed A. Lebda, et al.
Publicado: (2021)

Size Matters: The Influence of Patient Size on Antibiotics Exposure Profiles in Critically Ill Patients on Continuous Renal Replacement Therapy
por: Soo-Min Jang, et al.
Publicado: (2021)

Administration of Supplemental L-Tyrosine with Phenelzine: A Clinical Literature Review [Expression of Concern]
por: Hinz M, et al.
Publicado: (2020)

Utilization of Healthcare Resources in Osteoarthritis: A Cost of Illness Analysis Based on Real-World Data in Italy
por: Colombo GL, et al.
Publicado: (2021)

Comparisons of Four Protein-Binding Models Characterizing the Pharmacokinetics of Unbound Phenytoin in Adult Patients Using Non-Linear Mixed-Effects Modeling
por: Heajin Jun, et al.
Publicado: (2020)

Population Pharmacokinetic Model of Plasma and Cellular Mycophenolic Acid in Kidney Transplant Patients from the CIMTRE Study
por: François Riglet, et al.
Publicado: (2020)

Modern approaches to pharmacotherapy of tuberculosis infection in children
por: Vasiliy E. Novikov, et al.
Publicado: (2021)

Pharmacological properties of selenium and its preparations: from antioxidant to neuroprotector
por: Igor F. Belenichev, et al.
Publicado: (2021)

Is antibiotics overuse justified when immediate intervention is not possible? A rapid evidence review
por: Nour Ibrahim, et al.
Publicado: (2021)

Book of Abstracts 38th Technology Days 9th and 10th September 2021
por: Molitorisová M.
Publicado: (2021)

Optimal management of Barrett&#39;s esophagus: pharmacologic, endoscopic, and surgical interventions
por: Konda VJA, et al.
Publicado: (2011)

Atazanavir–bilirubin interaction: a pharmacokinetic–pharmacodynamic model [Corrigendum]
por: Lozano R, et al.
Publicado: (2013)

AAS, growth hormone, and insulin abuse: psychological and neuroendocrine effects
por: Michael R Graham, et al.
Publicado: (2008)

Impact of denosumab on bone mass in cancer patients
por: Brown-Glaberman U, et al.
Publicado: (2013)